The University of Tennessee System will launch a search for Schwab’s replacement in the coming weeks.
Credit: University of Tennessee Health Science Center
Chancellor Steve Schwab Published: 1:11 PM CDT June 1, 2021 Updated: 1:13 PM CDT June 1, 2021
MEMPHIS, Tenn. University of Tennessee Health Science Center Chancellor Steve Schwab announced today that he plans to retire.
The University of Tennessee System will launch a search for Schwab’s replacement in the coming weeks. He will continue to serve as chancellor until June 30, 2022, or until a successor is on board.
“It has been my honor work beside Chancellor Schwab these past few years,” UT President Randy Boyd said. “He had to be a brilliant doctor and researcher to earn his position, and he obviously is both of those. But in the role, he has proven to also be a great strategist and great leader. He is always honest and direct, has bold vision, and gets things done. The UT famil
Researchers receive $4 5 million grant to improve quality of care for people with cardiovascular disease news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
The Clinical Trials Network of Tennessee (CTN2) at the University of Tennessee Health Science Center has contracted a new clinical trial to test possible therapeutics for COVID-19 in hospitalized patients. This new trial brings the total generated by CTN2 contracts for the university to nearly $7 million.
E-Mail
DALLAS, May 10, 2021 In a small study, researchers found college athletes who contracted COVID-19 rarely had cardiac complications. Most had mild COVID symptoms that did not require treatment, and in a small percentage of those with abnormal cardiac testing, there was no evidence of heart damage on special imaging tests. All athletes returned to sports without any health concerns, according to new research published today in the American Heart Association’s flagship journal
Circulation.
In spring 2020, concerns about heart damage, especially inflammation, among athletes with COVID-19 led to recommendations for cardiac screening based on symptom severity before resuming training and competition. The preferred diagnostic test for heart inflammation is an MRI of the heart, or cardiac magnetic resonance imaging. The American College of Cardiology’s Sports & Exercise Cardiology Council’s standard recommendations, issued in May 2020, do not advise cardiac MRI as an ini
Cardiac complications found to be rare in college athletes who contracted COVID-19
In a small study, researchers found college athletes who contracted COVID-19 rarely had cardiac complications. Most had mild COVID symptoms that did not require treatment, and in a small percentage of those with abnormal cardiac testing, there was no evidence of heart damage on special imaging tests. All athletes returned to sports without any health concerns, according to new research published today in the American Heart Association s flagship journal
Circulation.
In spring 2020, concerns about heart damage, especially inflammation, among athletes with COVID-19 led to recommendations for cardiac screening based on symptom severity before resuming training and competition. The preferred diagnostic test for heart inflammation is an MRI of the heart, or cardiac magnetic resonance imaging. The American College of Cardiology s Sports & Exercise Cardiology Council s standard recommendations, issued in